FDA approves Aurobindo's OTC cetirizine liquid
This article was originally published in The Tan Sheet
Executive SummaryThe agency approves Aurobindo Pharma Limited's cetirizine hydrochloride solution, which the Hyderabad, India-based firm plans to launch "shortly." The product is the generic equivalent of McNeil Consumer Healthcare's Children's Zyrtec Allergy and Children's Zyrtec Hives Relief, both oral solutions containing cetirizine HCl and packaged in 1 mg/mL bottles. It will join the growing number of products in the category, which for the 52 weeks ended Jan. 24 had sales of $630.9 million, according to data from Information Resources, Inc. a Chicago-based market research firm. Private-label products in the category sold $149.3 million in the same period, while Johnson & Johnson/McNeil's liquid and powder Zyrtec products sold $26.4 million and Schering-Plough's Claritin liquid/powder products sold $12.7 million
You may also be interested in...
The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.
Japanese companies agree to discontinue regenerative cell therapy pact after high-profile Phase II failure, but SanBio will move ahead with development and Dainippon will hold onto ex-partner stake for now.